Recently, increasing evidence has shown that upregulation of EphA2 along with downregulation of its ligands, including ephrin-A1, disrupts orderly epithelial adhesion of cancer cells, suggesting ligand-independent functions of EphA2 in tumour microenvironments4, 17. The gene discussed is EPHA2; the disease is cancer.